|
1
|
Yamamoto T and Keighley MR: Long-term
results of strictureplasty for ileocolonic anastomotic recurrence
in Crohn's disease. J Gastrointest Surg. 3:555–560. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
De Cruz P, Kamm MA, Hamilton AL, Ritchie
KJ, Krejany EO, Gorelik A, Liew D, Prideaux L, Lawrance IC, Andrews
JM, et al: Crohn's disease management after intestinal resection: A
randomised trial. Lancet. 385:1406–1417. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ananthakrishnan AN: Surgery for Crohn's
disease: Look harder, act faster. Lancet. 385:1370–1371. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Froehlich F, Juillerat P, Mottet C, Felley
C, Vader JP, Burnand B, Gonvers JJ and Michetti P: Obstructive
fibrostenotic Crohn's disease. Digestion. 71:29–30. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Legnani PE and Kornbluth A: Therapeutic
options in the management of strictures in Crohn's disease.
Gastrointest Endosc Clin N Am. 12:589–603. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pennington L, Hamilton SR, Bayless TM and
Cameron JL: Surgical management of Crohn's disease. Influence of
disease at margin of resection. Ann Surg. 192:311–318. 1980.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Han R, Rostami-Yazdi M, Gerdes S and
Mrowietz U: Triptolide in the treatment of psoriasis and other
immune-mediated inflammatory diseases. Br J Clin Pharmacol.
74:424–436. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ren J, Tao Q, Wang X, Wang Z and Li J:
Efficacy of T2 in active Crohn's disease: A prospective study
report. Dig Dis Sci. 52:1790–1797. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jiang C, Fang X, Zhang H, Wang X, Li M,
Jiang W, Tian F, Zhu L and Bian Z: Triptolide inhibits the growth
of osteosarcoma by regulating microRNA-181a via targeting PTEN gene
in vivo and vitro. Tumour Biol. 39:10104283176975562017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang Z, Qu X, Ni Y, Zhang K, Dong Z, Yan
X, Qin J, Sun H, Ding Y, Zhao P and Gong K: Triptolide protects rat
heart against pressure overload-induced cardiac fibrosis. Int J
Cardiol. 168:2498–2505. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hou HW, Wang JM, Wang D, Wu R and Ji ZL:
Triptolide exerts protective effects against fibrosis following
ileocolonic anastomosis by mechanisms involving the miR-16-1/HSP70
pathway in IL-10-deficient mice. Int J Mol Med. 40:337–346. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li F, Xu Y, Deng S, Li Z, Zou D, Yi S, Sui
W, Hao M and Qiu L: MicroRNA-15a/16-1 cluster located at chromosome
13q14 is down-regulated but displays different expression pattern
and prognostic significance in multiple myeloma. Oncotarget.
6:38270–38282. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bonci D, Coppola V, Musumeci M, Addario A,
D'Urso L, Collura D, Peschle C, De Maria R and Muto G: The
Mir-15a/Mir-16-1 cluster controls prostate cancer progression
control by targeting of multiple oncogenic activities. J Urol.
181:1882009. View Article : Google Scholar
|
|
14
|
Bottoni A, Piccin D, Tagliati F, Luchin A,
Zatelli MC and degli Uberti EC: miR-15a and miR-16-1
down-regulation in pituitary adenomas. J Cell Physiol. 204:280–285.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sam S, Sam MR, Esmaeillou M and
Safaralizadeh R: Effective targeting survivin, caspase-3 and
MicroRNA-16-1 expression by Methyl-3-pentyl-6-methoxyprodigiosene
triggers apoptosis in colorectal cancer stem-like cells. Pathol
Oncol Res. 24:715–723. 2016. View Article : Google Scholar
|
|
16
|
Iborra M, Bernuzzi F, Correale C, Vetrano
S, Fiorino G, Beltrán B, Marabita F, Locati M, Spinelli A, Nos P,
et al: Identification of serum and tissue micro-RNA expression
profiles in different stages of inflammatory bowel disease.
Clinical and experimental immunology. 173:250–258. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Paraskevi A, Theodoropoulos G,
Papaconstantinou I, Mantzaris G, Nikiteas N and Gazouli M:
Circulating MicroRNA in inflammatory bowel disease. J Crohns
Colitis. 6:900–904. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sherman MY and Gabai VL: Hsp70 in cancer:
Back to the future. Oncogene. 34:4153–4161. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Murphy ME: The HSP70 family and cancer.
Carcinogenesis. 34:1181–1188. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Calderwood SK and Gong J: Heat shock
proteins promote cancer: It's a protection racket. Trends Biochem
Sci. 41:311–323. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang C, Zhang Y, Guo K, Wang N, Jin H, Liu
Y and Qin W: Heat shock proteins in hepatocellular carcinoma:
Molecular mechanism and therapeutic potential. Int J Cancer.
138:1824–1834. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Miller SB, Mogk A and Bukau B: Spatially
organized aggregation of misfolded proteins as cellular stress
defense strategy. J Mol Biol. 427:1564–1574. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sevin M, Girodon F, Garrido C and de
Thonel A: HSP90 and HSP70: Implication in inflammation processes
and therapeutic approaches for myeloproliferative neoplasms.
Mediators Inflamm. 2015:9702422015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mohanan V and Grimes CL: The molecular
chaperone HSP70 binds to and stabilizes NOD2, an important protein
involved in Crohn disease. J Biol Chem. 289:18987–18998. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bellaye PS, Burgy O, Causse S, Garrido C
and Bonniaud P: Heat shock proteins in fibrosis and wound healing:
Good or evil? Pharmacol Ther. 143:119–132. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tanaka K, Tanaka Y, Namba T, Azuma A and
Mizushima T: Heat shock protein 70 protects against
bleomycin-induced pulmonary fibrosis in mice. Biochem Pharmacol.
80:920–931. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang Z and Cheng Y: miR-16-1 promotes the
aberrant alpha-synuclein accumulation in parkinson disease via
targeting heat shock protein 70. ScientificWorldJournal.
2014:9383482014.PubMed/NCBI
|
|
28
|
Wang S, Wang X, Yan J, Xie X, Fan F, Zhou
X, Han L and Chen J: Resveratrol inhibits proliferation of cultured
rat cardiac fibroblasts: Correlated with NO-cGMP signaling pathway.
Eur J Pharmacol. 567:26–35. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Olson ER, Naugle JE, Zhang X, Bomser JA
and Meszaros JG: Inhibition of cardiac fibroblast proliferation and
myofibroblast differentiation by resveratrol. Am J Physiol Heart
Circ Physiol. 288:H1131–H1138. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shi H, Zhang X, He Z, Wu Z, Rao L and Li
Y: Metabolites of hypoxic cardiomyocytes induce the migration of
cardiac fibroblasts. Cell Physiol Biochem. 41:413–421. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang Y, Jia L and Wu CY: Triptolide
inhibits the differentiation of Th17 cells and suppresses
collagen-induced arthritis. Scand J Immunol. 68:383–390. 2010.
View Article : Google Scholar
|
|
32
|
Zhu KJ, Shen QY, Cheng H, Mao XH, Lao LM
and Hao GL: Triptolide affects the differentiation, maturation and
function of human dendritic cells. Int Immunopharmacol.
5:1415–1426. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li Y, Yu C, Zhu WM, Xie Y, Qi X, Li N and
Li JS: Triptolide ameliorates IL-10-deficient mice colitis by
mechanisms involving suppression of IL-6/STAT3 signaling pathway
and down-regulation of IL-17. Mol Immunol. 47:2467–2474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wei X, Gong J, Zhu J, Wang P, Li N, Zhu W
and Li J: The suppressive effect of triptolide on chronic colitis
and TNF-alpha/TNFR2 signal pathway in interleukin-10 deficient
mice. Clin Immunol. 129:211–218. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yu C, Shan T, Feng A, Li Y, Zhu W, Xie Y,
Li N and Li J: Triptolide ameliorates Crohn's colitis is associated
with inhibition of TLRs/NF-κB signaling pathway. Fitoterapia.
82:709–715. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cao Y, Huang X, Fan Y and Chen X:
Protective effect of triptolide against glomerular mesangial cell
proliferation and glomerular fibrosis in rats involves the TGF-β
1/Smad signaling pathway. Evid Based Complement Alternat Med.
2015:8140892015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen C, Yang S, Zhang M, Zhang Z, Hong J,
Han D, Ma J, Zhang SB, Okunieff P and Zhang L: Triptolide mitigates
radiation-induced pulmonary fibrosis via inhibition of axis of
alveolar macrophages-NOXes-ROS-myofibroblasts. Cancer Biol Ther.
17:381–389. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu M, Chen J, Huang Y, Ke J, Li L, Huang
D and Wu W: Triptolide alleviates isoprenaline-induced cardiac
remodeling in rats via TGF-β1/Smad3 and p38 MAPK signaling pathway.
Pharmazie. 70:244–250. 2015.PubMed/NCBI
|
|
40
|
Wang F, Fu XD, Zhou Y and Zhang Y:
Down-regulation of the cyclin E1 oncogene expression by
microRNA-16-1 induces cell cycle arrest in human cancer cells. BMB
Rep. 42:725–730. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Acunzo M and Croce CM: Downregulation of
miR-15a and miR-16-1 at 13q14 in chronic lymphocytic leukemia. Clin
Chem. 62:655–656. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Cai CK, Zhao GY, Tian LY, Liu L, Yan K, Ma
YL, Ji ZW, Li XX, Han K, Gao J, et al: miR-15a and miR-16-1
downregulate CCND1 and induce apoptosis and cell cycle arrest in
osteosarcoma. Oncol Rep. 28:1764–1770. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Meng HT, Zhu L, Ni WM, You LS, Jin J and
Qian WB: Triptolide inhibits the proliferation of cells from
lymphocytic leukemic cell lines in association with downregulation
of NF-κB activity and miR-16-1*. Acta Pharmacol Sin. 32:503–511.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Klausz G, Molnár T, Nagy F, Gyulai Z, Boda
K, Lonovics J and Mándi Y: Polymorphism of the heat-shock protein
gene Hsp70-2, but not polymorphisms of the IL-10 and CD14 genes, is
associated with the outcome of Crohn's disease. Scand J
Gastroenterol. 40:1197–1204. 2009. View Article : Google Scholar
|
|
45
|
Li Y, Kang X and Wang Q: HSP70 decreases
receptor-dependent phosphorylation of Smad2 and blocks
TGF-β-induced epithelial-mesenchymal transition. J Genet Genomics.
38:111–116. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yun CH, Yoon SY, Nguyen TT, Cho HY, Kim
TH, Kim ST, Kim BC, Hong YS, Kim SJ and Lee HJ: Geldanamycin
inhibits TGF-beta signaling through induction of Hsp70. Arch
Biochem Biophys. 495:8–13. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Fujibayashi T, Hashimoto N, Jijiwa M,
Hasegawa Y, Kojima T and Ishiguro N: Protective effect of
geranylgeranylacetone, an inducer of heat shock protein 70, against
drug-induced lung injury/fibrosis in an animal model. BMC Pulm Med.
9:452009. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
He W, Zhuang Y, Wang L, Qi L, Chen B, Wang
M, Shao D and Chen J: Geranylgeranylacetone attenuates hepatic
fibrosis by increasing the expression of heat shock protein 70. Mol
Med Rep. 12:4895–4900. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Mao H, Li Z, Zhou Y, Li Z, Zhuang S, An X,
Zhang B, Chen W, Nie J, Wang Z, et al: HSP72 attenuates renal
tubular cell apoptosis and interstitial fibrosis in obstructive
nephropathy. Am J Physiol Renal Physiol. 295:F202–F214. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhou Y, Mao H, Li S, Cao S, Li Z, Zhuang
S, Fan J, Dong X, Borkan SC, Wang Y and Yu X: HSP72 inhibits Smad3
activation and nuclear translocation in renal
epithelial-to-mesenchymal transition. J Am Soc Nephrol. 21:598–609.
2010. View Article : Google Scholar : PubMed/NCBI
|
